Shenzhen Chipscreen Biosciences Co., Ltd.

SHSE:688321 Stock Report

Market Cap: CN¥7.4b

Shenzhen Chipscreen Biosciences Management

Management criteria checks 2/4

Shenzhen Chipscreen Biosciences' CEO is Xian-Ping Lu, appointed in Jan 2001, has a tenure of 6.83 years. directly owns 5.45% of the company’s shares, worth CN¥402.09M. The average tenure of the management team and the board of directors is 15.4 years and 6.8 years respectively.

Key information

Xian-Ping Lu

Chief executive officer

CN¥3.4m

Total compensation

CEO salary percentagen/a
CEO tenure24yrs
CEO ownership5.5%
Management average tenure15.4yrs
Board average tenure6.8yrs

Recent management updates

Recent updates

Shenzhen Chipscreen Biosciences Co., Ltd.'s (SHSE:688321) 50% Price Boost Is Out Of Tune With Revenues

Oct 08
Shenzhen Chipscreen Biosciences Co., Ltd.'s (SHSE:688321) 50% Price Boost Is Out Of Tune With Revenues

Shenzhen Chipscreen Biosciences Co., Ltd.'s (SHSE:688321) Price In Tune With Revenues

Aug 21
Shenzhen Chipscreen Biosciences Co., Ltd.'s (SHSE:688321) Price In Tune With Revenues

We Think Shenzhen Chipscreen Biosciences (SHSE:688321) Has A Fair Chunk Of Debt

Jun 04
We Think Shenzhen Chipscreen Biosciences (SHSE:688321) Has A Fair Chunk Of Debt

Investors Appear Satisfied With Shenzhen Chipscreen Biosciences Co., Ltd.'s (SHSE:688321) Prospects As Shares Rocket 26%

Apr 24
Investors Appear Satisfied With Shenzhen Chipscreen Biosciences Co., Ltd.'s (SHSE:688321) Prospects As Shares Rocket 26%

Solid Earnings May Not Tell The Whole Story For Shenzhen Chipscreen Biosciences (SHSE:688321)

Apr 05
Solid Earnings May Not Tell The Whole Story For Shenzhen Chipscreen Biosciences (SHSE:688321)

Shenzhen Chipscreen Biosciences Co., Ltd.'s (SHSE:688321) Shares Climb 30% But Its Business Is Yet to Catch Up

Mar 06
Shenzhen Chipscreen Biosciences Co., Ltd.'s (SHSE:688321) Shares Climb 30% But Its Business Is Yet to Catch Up

CEO

Xian-Ping Lu (60 yo)

24yrs

Tenure

CN¥3,384,700

Compensation

Dr. Xian-Ping Lu Founded Shenzhen Chipscreen Biosciences Ltd. in 2001 and has been its Chairman since March 2018. Dr. Lu has been Chief Executive Officer, General Manager and President of Shenzhen Chipscre...

Leadership Team

NamePositionTenureCompensationOwnership
Xian-Ping Lu
Founder24yrsCN¥3.38m5.45%
CN¥ 402.1m
Jian-Xun Li
VP, Deputy GM6.8yrsCN¥1.32m0.0091%
CN¥ 668.7k
Desi Pan
VP, Deputy GM5yrsCN¥1.21m0.018%
CN¥ 1.3m
Ou Hai
VP, Deputy GM6.8yrsCN¥1.02m0.018%
CN¥ 1.3m
Zhi-Bin Li
VP, Deputy GM and Head of Product Development & Productionno dataCN¥1.35m0.0045%
CN¥ 334.7k
Liangji She
VP, Deputy GM & Head of Oncology Divisionno dataCN¥1.47m0.0097%
CN¥ 711.5k
Libin Zhang
VP, Deputy GM & Head of Metabolic Diseases Divisionno dataCN¥1.36m0.0098%
CN¥ 723.3k
Leming Shi
Co-Founder24yrsno datano data
Weiming Hu
Co-Founder24yrsno datano data
Ji-Hui Yi
Vice President of Sales & Marketingno datano datano data

15.4yrs

Average Tenure

53yo

Average Age

Experienced Management: 688321's management team is seasoned and experienced (15.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Xian-Ping Lu
Founder6.8yrsCN¥3.38m5.45%
CN¥ 402.1m
Jian-Xun Li
VP, Deputy GM6.8yrsCN¥1.32m0.0091%
CN¥ 668.7k
Ou Hai
VP, Deputy GM6.8yrsCN¥1.02m0.018%
CN¥ 1.3m
Rui Lin Song
Independent Director6.8yrsCN¥150.00kno data
Xun Zhu
Independent Director6.8yrsCN¥150.00kno data
Hanpeng Yang
Directorno dataCN¥96.00kno data
Xiangyan Li
Independent Director6.8yrsCN¥150.00kno data
Zhengsheng Xie
Supervisor3.8yrsno data0.54%
CN¥ 39.6m
Jingzhong Zhu
Employee Supervisor5.1yrsno datano data
Jie He
Employee Supervisor5.1yrsno datano data
Xia Jin
Employee Supervisor3.8yrsno datano data
Weihua Li
Director1.1yrsno datano data

6.8yrs

Average Tenure

50.5yo

Average Age

Experienced Board: 688321's board of directors are considered experienced (6.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 08:24
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shenzhen Chipscreen Biosciences Co., Ltd. is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhizhong JingChina Merchants Securities Co. Ltd.
Bin WuChina Merchants Securities Co. Ltd.
Yinglan ShuHaitong International Research Limited